You have 9 free searches left this month | for more free features.

ACUTE MYELOID LEUKEMIA

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

Not yet recruiting
  • Chemotherapy-Induced Thrombocytopenia
  • Hetrombopag Olamine
  • (no location specified)
Jul 5, 2023

Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

Recruiting
  • Refractory/Relapse Acute Myeloid Leukemia
  • Kunming, Yunnan, China
    Department of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023

Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

Recruiting
  • Acute Myeloid Leukemia, Adult
  • cladribine + homoharringtonine + cytarabine
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • B7-H3 target, CAR gene modified gdT cell injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Feb 15, 2023

Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)

Not yet recruiting
  • Acute Myeloid Leukemia
  • CLL1/+CD33 CAR-T
  • Fuzhou, Fujian, China
    Fujian Provincial Children's Hospital
Jul 10, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

    Active, not recruiting
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Venetoclax Plasma Concentration and Remission in Acute Myeloid

    Not yet recruiting
    • Adult Acute Myeloid Leukemia
    • Blood sampling for venetoclax drug dosage (venous puncture)
    • (no location specified)
    Sep 13, 2023

    Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Suzhou, Jiangsu, China
      Qiu Huiying
    Mar 28, 2023

    Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)

    Recruiting
    • Acute Myeloid Leukemia
    • CIML-NK Cells
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Jan 4, 2023

    Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

    Recruiting
    • Relapsed or Refractory Acute Myeloid Leukemia
    • Taiyuan, Shanxi, China
      Tao Wang
    Feb 9, 2023

    GilteRInf 2022 Study (Gilteritinib Related Infections)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Roma, RM, Italy
      Maria Ilaria Del Principe
    Mar 17, 2023

    AML Trial in Guanzhou (CLAG)

    Not yet recruiting
    • AML
    • CLAG
    • Guanzhou, Guangdong, China
    • +1 more
    May 16, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Recruiting
    • Acute Bilineal Leukemia
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 24, 2023

    Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome With Excess Blasts-2
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 26, 2023

    Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])

    Not yet recruiting
    • Acute Myeloid Leukemia
    • NK cells
    • Talazoparib 1 MG [Talzenna]
    • (no location specified)
    Jan 9, 2023

    Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Anti-CD33 CAR T-cells
    • Lymphodepletion Therapy
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jul 21, 2023

    Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Houston, Texas
      M.D. Anderson Cancer Center
    Apr 17, 2023

    Acute Myeloid Leukemia Trial in Valencia (AFM28)

    Recruiting
    • Acute Myeloid Leukemia
    • Valencia, Spain
      Hospital Universitari i Politècnic La Fe
    Apr 5, 2023

    Acute Myeloid Leukemia Trial in United States (Standard Leukemia Care, Palliative Care)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Standard Leukemia Care
    • Palliative Care
    • Boston, Massachusetts
    • +3 more
    Jan 24, 2023

    Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

    Not yet recruiting
    • Myelodysplastic Syndrome
    • +4 more
    • UAE Inhibitor TAK-243
    • (no location specified)
    Oct 20, 2022